Neddylation inhibitor MLN4924 has anti‐HBV activity via modulating the ERK‐HNF1α‐C/EBPα‐HNF4α axisMingjie Xie, Min Zheng|Journal of Cellular and Molecular Medicine|2020Cited by 36